Akthelia

Immunomodulatory therapy for febrile neutropenia without the risk of antibiotic resistance; Phase 1a clinical trials of a new drug indication.

aktheliapharma.com

Related shoots

We use cookies 🍪

We use cookies to improve your experience, analyze site usage, and support the continued development of our services. By clicking "Accept All", you consent to their use.